CD44 Identified as a Diagnostic Biomarker for Highly Malignant CA19-9 Negative Pancreatic Cancer

Published: 17 January 2025| Version 1 | DOI: 10.17632/y3m5v3xk5y.1
Contributor:
jiatong tang

Description

The raw data for "CD44 Identified as a Diganositc Biomarker for Highly Malignant CA19-9 Negative Pancreatic Cancer".

Files

Institutions

Nanjing University

Categories

Raw Materials Substitution

Licence